Press & News

2019-11-15

Affibody Medical AB (publ) (“Affibody” or “the Company”), a Swedish biotechcompany focused on developing next...[read more]

Financial Calendar

2019

November
Interim Report Q3 – Nov. 15, 2019

Affibodys latest Press releases

2019-11-15

Interim Report – January to September 2019

Affibody Medical AB (publ) (“Affibody” or “the Company”), a Swedish biotechcompany focused on developing next generation biopharmaceuticals based on its...[read more]

Press & News

Affibody in short

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

About Affibody

Upcoming reports Financial calendar

Interim Report Q3 (Nov. 15, 2019)

Investor information